Bio-Rad Laboratories Reports Q3 Revenue of $656.4 Million and GAAP EPS of $2.65
Bio-Rad Laboratories (BIO) reported third-quarter financial results, posting a GAAP earnings per share (EPS) of $2.65. The company's revenue for the quarter reached $656.4 million, representing a 0.5% increase year-over-year and exceeding market expectations by approximately $6.45 million. The results come amidst various investor engagements, including presentations at the Bernstein Insights Healthcare Forum and the Wells Fargo 21st Annual Healthcare Conference. These events highlight ongoing investor interest in the company's position within the healthcare sector.
Tickers: $BIO
Topics: earnings report GAAP EPS revenue beat